Please ensure Javascript is enabled for purposes of website accessibility
Accueil > Support > Références

Design and Structural Optimization of Orally Bioavailable SOS1 Inhibitors for the Treatment of KRAS-Driven Carcinoma

Date de publication : 2022-11-17  Nombre de vues : 31
Recommandation

Obtenir un devis gratuit